Hypha Labs, Inc. (FUNI) Form 10-Q — May 15, 2026
Hypha Labs reported a net loss of $1.04 million for the six months ended March 31, 2026, with zero revenue generated. The company holds only $82,200 in cash against total liabilities of $2.94 million, resulting in negative working capital of $1.34 million and an accumulated deficit of $24.7 million. The filing includes explicit going-concern language, stating that these factors raise substantial doubt about the Company’s ability to continue as a going concern. Management acknowledges the need to raise additional funds through equity or debt to complete the development of its Hypha Micropearl bioreactor and fund operations, with no assurance of success.
Key figures
- Revenue
- 0
- Total Debt
- 1839852
- Cash Position
- 82200
- Shares Outstanding
- 163895977
- Notes Payable
- 416613
- Default Penalty
- 44765
- Regulation AProceeds
- 57484
- Convertible Notes Payable
- 1384582
- Interest Expense Six Months
- 147339
Price after filing
Close on the filing date to close N calendar days later (from $0.03). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.